Zunsemetinib (CDD-450) is an orally active and selective p38alpha mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1].
Molecular Weight:
513.92
Purity:
99.99
CAS Number:
[1640282-42-3]
Formula:
C25H22ClF2N5O3
Target:
MAPKAPK2 (MK2)
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted